MAPT and Alzheimer disease: To clarify the roles and contribution of EVA1C to AD pathology and progression, we used several tauopathy models including human SH-SY5Y cells overexpressing 2N3R Tau, hTau[P301L] C. elegans, hTau.P301S mice, and human brain tissue.